24239247|t|An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
24239247|a|BACKGROUND: Alzheimer's disease (AD) is the most common cause of dementia; the main risk factors are age and several recently identified genes. A major challenge for AD research is the early detection of subjects at risk. The aim of this study is to develop a predictive model using proton magnetic resonance spectroscopy (1H-MRS), a noninvasive technique that evaluates brain chemistry in vivo, for monitoring the clinical outcome of carriers of a fully penetrant mutation that causes AD. METHODS: We studied 75 subjects from the largest multigenerational pedigree in the world (~5000 people) that segregates a unique form of early-onset Alzheimer's disease (EOAD) caused by a fully penetrant mutation in the Presenilin-1 gene (PSEN1 p.Glu280Ala [E280 A]). Forty-four subjects were carriers of the mutation, and 31 were noncarriers. Seventeen carriers had either mild cognitive impairment (MCI) or early-stage AD (collectively MCI-AD). In right and left parietal white mater and parasagittal parietal gray matter (RPPGM and LPPGM) of the posterior cingulate gyrus and precuneus, we measured levels of the brain metabolites N-acetylaspartate (NAA), inositol (Ins), choline (Cho), and glutamate-glutamine complex (Glx) relative to creatine (Cr) levels (NAA/Cr, Ins/Cr, Cho/Cr, and Glx/Cr, respectively) with two-dimensional 1H-MRS. Using advanced recursive partition analysis and random forest analysis, we built classificatory decision trees for both mutation carrier status and the presence of MCI-AD symptoms, fitting them to 1H-MRS data while controlling for age, educational level, and sex. RESULTS: We found that (1) the combination of LPPGM Cho/Cr<0.165 and RPPGM Glx/Cr>1.54 fully excluded carriers; (2) LPPGM Cho/Cr>0.165, RPPGM Glx/Cr<1.54, and left parietal white mater NAA/Cr>1.16 identified asymptomatic carriers with sensitivity of 97.7% and specificity of 77.4%; and (3) RPPGM NAA/Cr>1.05 defined asymptomatic subjects (independent of carrier status) with sensitivity of 100% and a specificity of 96.6%. CONCLUSIONS: Brain metabolites measured by 1H-MRS in the posterior cingulate gyrus and precuneus are optimally sensitive and specific potential noninvasive biomarkers of subclinical emergence of AD caused by the PSEN1 p.Glu280Ala (E280 A) mutation.
24239247	3	5	1H	Chemical	-
24239247	42	61	Alzheimer's disease	Disease	MESH:D000544
24239247	74	79	PSEN1	Gene	5663
24239247	111	130	Alzheimer's disease	Disease	MESH:D000544
24239247	132	134	AD	Disease	MESH:D000544
24239247	164	172	dementia	Disease	MESH:D003704
24239247	265	267	AD	Disease	MESH:D000544
24239247	422	424	1H	Chemical	-
24239247	585	587	AD	Disease	MESH:D000544
24239247	738	757	Alzheimer's disease	Disease	MESH:D000544
24239247	759	763	EOAD	Disease	MESH:D000544
24239247	809	821	Presenilin-1	Gene	5663
24239247	828	833	PSEN1	Gene	5663
24239247	834	845	p.Glu280Ala	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
24239247	847	853	E280 A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
24239247	968	988	cognitive impairment	Disease	MESH:D003072
24239247	990	993	MCI	Disease	MESH:D060825
24239247	1010	1012	AD	Disease	MESH:D000544
24239247	1027	1033	MCI-AD	Disease	MESH:D060825
24239247	1114	1119	RPPGM	Chemical	-
24239247	1124	1129	LPPGM	Chemical	-
24239247	1223	1240	N-acetylaspartate	Chemical	MESH:C000179
24239247	1242	1245	NAA	Chemical	MESH:C000179
24239247	1248	1256	inositol	Chemical	MESH:D007294
24239247	1258	1261	Ins	Chemical	MESH:D007294
24239247	1264	1271	choline	Chemical	MESH:D002794
24239247	1273	1276	Cho	Chemical	MESH:D002794
24239247	1283	1302	glutamate-glutamine	ProteinMutation	tmVar:p|SUB|E||Q;VariantGroup:1;CorrespondingGene:5663;CorrespondingSpecies:9606
24239247	1329	1337	creatine	Chemical	MESH:D003401
24239247	1339	1341	Cr	Chemical	MESH:D003401
24239247	1351	1354	NAA	Chemical	MESH:C000179
24239247	1355	1357	Cr	Chemical	MESH:D003401
24239247	1359	1362	Ins	Chemical	MESH:D007294
24239247	1363	1365	Cr	Chemical	MESH:D003401
24239247	1367	1370	Cho	Chemical	MESH:D002794
24239247	1371	1373	Cr	Chemical	MESH:D003401
24239247	1383	1385	Cr	Chemical	MESH:D003401
24239247	1422	1424	1H	Chemical	-
24239247	1594	1600	MCI-AD	Disease	MESH:D060825
24239247	1627	1629	1H	Chemical	-
24239247	1740	1745	LPPGM	Chemical	-
24239247	1746	1749	Cho	Chemical	MESH:D002794
24239247	1750	1752	Cr	Chemical	MESH:D003401
24239247	1763	1768	RPPGM	Chemical	-
24239247	1773	1775	Cr	Chemical	MESH:D003401
24239247	1810	1815	LPPGM	Chemical	-
24239247	1816	1819	Cho	Chemical	MESH:D002794
24239247	1820	1822	Cr	Chemical	MESH:D003401
24239247	1830	1835	RPPGM	Chemical	-
24239247	1840	1842	Cr	Chemical	MESH:D003401
24239247	1879	1882	NAA	Chemical	MESH:C000179
24239247	1883	1885	Cr	Chemical	MESH:D003401
24239247	1984	1989	RPPGM	Chemical	-
24239247	1990	1993	NAA	Chemical	MESH:C000179
24239247	1994	1996	Cr	Chemical	MESH:D003401
24239247	2160	2162	1H	Chemical	-
24239247	2312	2314	AD	Disease	MESH:D000544
24239247	2329	2334	PSEN1	Gene	5663
24239247	2335	2346	p.Glu280Ala	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
24239247	2348	2354	E280 A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
24239247	Positive_Correlation	MESH:D003072	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
24239247	Positive_Correlation	MESH:D060825	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
24239247	Association	MESH:D003401	CorrespondingGene:5663;CorrespondingSpecies:9606;VariantGroup:1;tmVar:p
24239247	Positive_Correlation	MESH:D000544	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
24239247	Association	MESH:D000544	5663
24239247	Association	MESH:D060825	5663
24239247	Association	MESH:D002794	5663
24239247	Association	MESH:D003072	5663
24239247	Association	MESH:D060825	5663
24239247	Association	MESH:D000544	5663

